-
Regulatory Perspective on Biomarkers and Surrogate Endpoints +
As the Director of the Evaluation of Radiopharmaceuticals and Biotherapeutic Products at Health Canada, Dr. Klein gives a brief background… Read More
-
Translation to Clinical Research/Practice (CAIN3) +
While imaging is recognized as a useful tool to characterize atherosclerosis and its complications, there is a critical need to… Read More
-
Imaging Biomarkers in Vascular Cognitive Impairment +
Using imaging to help unravel the complex relationships between vascular disease and cognitive impairment is the outline for this presentation.… Read More
-
Translational Development of Novel Ligands for Cardiac and Renal Diseases +
The Ottawa Heart Institute is active in the development of novel radiopharmaceutical agents for PET imaging of cardiac diseases. Dr.… Read More
-
Measuring Tissue Perfusion with Magnetic Resonance +
The ability to calculate tissue perfusion accurately is clinically important challenge. Using magnetic resonance imaging, Dr. Frayne discusses two approaches… Read More
- 1
- 2
›
‹